Company News

DSM Receives Registration Approval for Syn-Up as New Cosmetic Ingredient in China

IP-protected, synthetic dipeptide derivative has broad efficacy and is suitable for a number of skincare applications.

Author Image

By: Lianna Albrizio

Associate Editor

Royal DSM’s skin care peptide Syn-Up has been approved as a new cosmetic ingredient (NCI) in China under the country’s new cosmetic legislation, and can be used freely in formulations across the globe. SYN-UP is a sophisticated, IP protected, synthetic dipeptide derivative. Its broad efficacy makes it suitable for use in a number of skin care applications.   The outcome makes DSM the first company to receive NCI approval in the stringent NCI category 3, and confirms that SYN-UP meets the...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters